Zobrazeno 1 - 10
of 248
pro vyhledávání: '"E, Tomassini"'
Autor:
Lindsey R. Baden, Hana M. El Sahly, Brandon Essink, Dean Follmann, Gregory Hachigian, Cynthia Strout, J. Scott Overcash, Susanne Doblecki-Lewis, Jennifer A. Whitaker, Evan J. Anderson, Kathleen Neuzil, Lawrence Corey, Frances Priddy, Joanne E. Tomassini, Mollie Brown, Bethany Girard, Dina Stolman, Veronica Urdaneta, Xiaowei Wang, Weiping Deng, Honghong Zhou, Avika Dixit, Rituparna Das, Jacqueline M. Miller, the COVE Trial Consortium
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-13 (2024)
Abstract Primary vaccination with mRNA-1273 (100-µg) was safe and efficacious at preventing coronavirus disease 2019 (COVID-19) in the previously reported, blinded Part A of the phase 3 Coronavirus Efficacy (COVE; NCT04470427) trial in adults (≥18
Externí odkaz:
https://doaj.org/article/b9044673d7cd478088d5513d33602744
Autor:
Spyros Chalkias, Charles Harper, Keith Vrbicky, Stephen R. Walsh, Brandon Essink, Adam Brosz, Nichole McGhee, Joanne E. Tomassini, Xing Chen, Ying Chang, Andrea Sutherland, David C. Montefiori, Bethany Girard, Darin K. Edwards, Jing Feng, Honghong Zhou, Lindsey R. Baden, Jacqueline M. Miller, Rituparna Das
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-7 (2023)
Abstract We previously presented day 29 interim safety and immunogenicity results from a phase 2/3 study (NCT04927065) comparing the Omicron-BA.1-containing bivalent vaccine mRNA-1273.214 (50-µg) to the 50-µg mRNA-1273 booster in adults who previou
Externí odkaz:
https://doaj.org/article/1a6753255d44434c95bc9554b61b13a6
Autor:
Hana M, El Sahly, Lindsey R, Baden, Brandon, Essink, David, Montefiori, Adrian, McDermont, Richard, Rupp, Michael, Lewis, Shobha, Swaminathan, Carl, Griffin, Veronica, Fragoso, Vicki E, Miller, Bethany, Girard, Yamuna D, Paila, Weiping, Deng, Joanne E, Tomassini, Robert, Paris, Florian, Schödel, Rituparna, Das, Allison, August, Brett, Leav, Jacqueline M, Miller, Honghong, Zhou, Rolando, Pajon
Publikováno v:
The Journal of Infectious Diseases. 226:1731-1742
Background Messenger RNA (mRNA)–1273 vaccine demonstrated 93.2% efficacy against coronavirus disease 2019 (COVID-19) in the Coronavirus Efficacy (COVE) trial. The humoral immunogenicity results are now reported. Methods Participants received 2 mRNA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e0959204de1603d5c910becbe7f0f85
https://doi.org/10.1093/infdis/jiac188
https://doi.org/10.1093/infdis/jiac188
Autor:
Michael H. Davidson, Joanne E. Tomassini, Erin Jensen, David Neff, Adam B. Polis, Andrew M. Tershakovec
Publikováno v:
Data in Brief, Vol 6, Iss , Pp 530-541 (2016)
This brief article provides complementary data supporting the results reported in “Changing Characteristics of Statin-related cIMT Trials from 1988 to 2006” [1]. That article described time-related trends in baseline factors and study characteris
Externí odkaz:
https://doaj.org/article/5d0fd302a53840b2831e707cf566197d
Autor:
Terrill McClanahan, Joanne E. Tomassini, Masahisa Handa, Tanguy Y. Seiwert, Laura Q.M. Chow, Jonathan Cheng, Jared Lunceford, Jonathan Juco, Erin Murphy, Christina Moon, Ni Yu, Christopher Gibson, Jennifer H. Yearley
Supplementary Figures S1-S5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64361e96b795e8de0c66995d095d08cd
https://doi.org/10.1158/1078-0432.22462622
https://doi.org/10.1158/1078-0432.22462622
Autor:
Terrill McClanahan, Joanne E. Tomassini, Masahisa Handa, Tanguy Y. Seiwert, Laura Q.M. Chow, Jonathan Cheng, Jared Lunceford, Jonathan Juco, Erin Murphy, Christina Moon, Ni Yu, Christopher Gibson, Jennifer H. Yearley
Purpose: Tumor-associated PD-L1 expression is predictive of clinical response to PD-1–directed immunotherapy. However, PD-L1–negative patients may also respond to PD-1 checkpoint blockade, suggesting that other PD-1 ligands may be relevant to the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::623c5753cf30c010ceb5fb87cbbb8f2d
https://doi.org/10.1158/1078-0432.c.6525152.v1
https://doi.org/10.1158/1078-0432.c.6525152.v1
Autor:
Ivan T. Lee, Catherine A. Cosgrove, Patrick Moore, Claire Bethune, Rhiannon Nally, Marcin Bula, Philip A. Kalra, Rebecca Clark, Paul I. Dargan, Marta Boffito, Ray Sheridan, Ed Moran, Thomas C. Darton, Fiona Burns, Dinesh Saralaya, Christopher J. A. Duncan, Patrick Lillie, Alberto San Francisco Ramos, Eva Galiza, Paul T. Heath, Bethany Girard, Christy Parker, Dondi Rust, Shraddha Mehta, Elizabeth de Windt, Andrea Sutherland, Joanne E. Tomassini, Frank J. Dutko, Spyros Chalkias, Weiping Deng, Xing Chen, LaRee Tracy, Honghong Zhou, Jacqueline M. Miller, Rituparna Das
BackgroundOmicron-containing bivalent boosters are available worldwide. Results of a large, randomized, active-controlled study are presented.MethodsThis phase 3, randomized, observer-blind, active-controlled trial in the United Kingdom evaluated the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be411cd32fa14d0dade51f9918f29e63
https://doi.org/10.1101/2023.01.24.23284869
https://doi.org/10.1101/2023.01.24.23284869
Autor:
Xiaoying, Shen, Spyros, Chalkias, Jing, Feng, Xing, Chen, Honghong, Zhou, Jean-Claude, Marshall, Bethany, Girard, Joanne E, Tomassini, Anne, Aunins, Rituparna, Das, David C, Montefiori
Publikováno v:
New England Journal of Medicine. 387:1234-1236
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83f943588996e523cf5a2863ae975549
https://doi.org/10.1056/nejmc2210648
https://doi.org/10.1056/nejmc2210648
Autor:
Spyros Chalkias, Jordan Whatley, Frank Eder, Brandon Essink, Shishir Khetan, Paul Bradley, Adam Brosz, Nichole McGhee, Joanne E. Tomassini, Xing Chen, Xiaoping Zhao, Andrea Sutherland, Xiaoying Shen, Bethany Girard, Darin K. Edwards, Jing Feng, Honghong Zhou, Stephen Walsh, David C. Montefiori, Lindsey R. Baden, Jacqueline M. Miller, Rituparna Das
BackgroundInformation on the safety and immunogenicity of the omicron BA.4/BA.5-containing bivalent booster mRNA-1273.222 are needed.MethodsIn this ongoing, phase 2/3 trial, 50-μg mRNA-1273.222 (25-μg each ancestral Wuhan-Hu-1 and omicron BA.4/BA.5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02a50fdfb4d770551bb62601c3408097
https://doi.org/10.1101/2022.12.11.22283166
https://doi.org/10.1101/2022.12.11.22283166
Autor:
Spyros Chalkias, Jing Feng, Xing Chen, Honghong Zhou, Jean-Claude Marshall, Bethany Girard, Joanne E. Tomassini, Barbara J. Kuter, David C. Montefiori, Rituparna Das
Publikováno v:
The New England journal of medicine. 387(23)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cac144aca2db3cdb89e6b43a6adf6a7c
https://pubmed.ncbi.nlm.nih.gov/36416761
https://pubmed.ncbi.nlm.nih.gov/36416761